Resound Vivia 9 60S microRIE vs Sony CRE-E10

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.

The Sony CRE-E10 is a mid-priced OTC hearing aid that earns an A grade with a SoundScore of 4.7/5, placing it in the top 3% of the 65 OTC hearing aids tested in our lab. At $998, this visible-in-ear style device delivers performance that competes with the best in its category. Speech performance is a standout strength. Speech in quiet scores a strong 4.3/5, sitting 1.46 points above the category average. Speech in noise reaches a solid 3.3/5, which is 1.77 points above average—a meaningful advantage for conversations in challenging environments. Music streaming quality is another highlight at 4.0/5, exceeding the category average by over 2 points, making it a strong choice for users who value audio fidelity when streaming from their iPhone. The device does have limitations. Own voice comfort scores a low 1.7/5, falling 0.81 points below the category average—users sensitive to the sound of their own voice may find this bothersome. Feedback handling is solid in absolute terms at 3.4/5 but sits 1.14 points below the category average, suggesting slightly less stability margin than many OTC competitors. The CRE-E10 is best suited for users who prioritize speech clarity and streaming quality and are less sensitive to own-voice perception. It has earned HearAdvisor's Expert's Choice Award for three consecutive years (2023–2025), reflecting its consistent strong performance in lab testing.